Skip to content

Clinical trials

Phase 3 Hypercholesterolemia trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypercholesterolemia Phase: Phase 3 Country / region: Czechia Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20051
20082
20091
20111
20123
20136
20142
20152
20163
20172
20181
20191
20212
20221
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28
Active, not recruiting3
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen12
Sanofi7
Novartis Pharmaceuticals4
Kastle Therapeutics, LLC2
Merck Sharp & Dohme LLC2
NewAmsterdam Pharma2
Takeda2
The Medicines Company2
AstraZeneca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypercholesterolemia34
Dyslipidemias9
Hyperlipidemias8
Hyperlipoproteinemia Type II6
Atherosclerosis2
Cardiovascular Diseases2
Homozygous Familial Hypercholesterolemia2
Aortic Valve Stenosis1
Coronary Artery Disease1
Coronary Disease1

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.